Morgan Stanley raises target for Clariant stock to CHF 8.10
Published on 10/24/2026 at 18:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- Morgan Stanley raised its Clariant target from CHF 7.00 to CHF 8.10 on October 6, 2026.
- Clariant's third-quarter and nine-month results are scheduled for November 3, 2026.
- Clariant stock costs EUR 10.86 at Lang & Schwarz on October 24, 2026 at 1:02 p.m. CEST, 0.09 percent above the gettex close of October 23, 2026.
Clariant (CH0012142631) received a higher valuation from Morgan Stanley, which raised its target from CHF 7.00 to CHF 8.10 on October 6, 2026, as reported by Stockopedia. The new target remains 19.24 percent below Clariant's SIX price of CHF 10.03 on October 23, 2026. At Lang & Schwarz, the stock was trading at EUR 10.86 on October 24, 2026 at 1:02 p.m. CEST, 0.09 percent above the gettex close of October 23, 2026.
What does the target imply?
Morgan Stanley's CHF 8.10 target is below the latest CHF 10.03 SIX quotation, creating a clear gap between the research view and the market level. Bernstein held a CHF 10.20 target on October 14, 2026, according to Markets Insider.
Stock position and trading range
The gettex quotation on October 23, 2026 placed Clariant at EUR 10.85, with a 52-week range of EUR 7.19 to EUR 11.73. The current Lang & Schwarz price is EUR 0.87, or 7.41 percent, below that 52-week high. The stock's year-to-date performance stood at plus 42.90 percent in the same market overview.
Valuation and next reporting date
Clariant's market capitalization was CHF 3.3 billion as of October 23, 2026, while its primary listing is on SIX under ticker CLN.S. The company paid a CHF 0.42 dividend per share for 2026, corresponding to a 4.10 percent yield. Boerse Express lists November 3, 2026 as the date for third-quarter and nine-month results.
Why the November date matters
The upcoming report will give investors a fresh operating checkpoint after Clariant's second-quarter sales reached CHF 941 million and its EBITDA margin before exceptional items was 18.20 percent, according to the company's earnings-call transcript published by Yahoo Finance. Management kept its 2026 margin outlook at around 18.00 percent before exceptional items, making the November figures the next dated test of that outlook.
Price and investor perspective
The market level is above the latest Morgan Stanley target but below Clariant's 52-week high. That combination leaves the November report as the next concrete point for comparing operating progress with analyst valuation.
The further course of trading is shown by the continuously updated real-time quote of Clariant stock.
Clariant at a glance
- Company: Clariant AG
- ISIN: CH0012142631
- Ticker: CLN.S
- Primary exchange: SIX
- Price Lang & Schwarz (as of October 24, 2026, 1:02 p.m. CEST): EUR 10.86
- Change versus gettex close: plus 0.09 percent
- Gettex close (October 23, 2026): EUR 10.85
- Market capitalization: CHF 3.3 billion (as of October 23, 2026)
- 52-week range: EUR 7.19-EUR 11.73 (as of October 23, 2026)
- Sector / Industry: Materials / Specialty Chemicals
- Next earnings date: November 3, 2026
Market context: Market report SMI.
